Chapter 12: GI Gram-Negative Rods & Enteric Pathogens
Loading audio…
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
GI Gram-Negative Rods & Enteric Pathogens facultative anaerobes, largely belonging to the family Enterobacteriaceae, are characterized by their ability to survive in various environments and their possession of lipopolysaccharide endotoxins. Escherichia coli serves as a primary example, naturally residing within the large intestine but capable of causing disease when it acquires specific virulence factors like plasmids or pathogenicity islands. The text details various E. coli strains, including those responsible for traveler's diarrhea, neonatal meningitis, and the life-threatening hemolytic uremic syndrome often linked to contaminated food. The discussion extends to Salmonella, distinguishing between common foodborne gastroenteritis and the systemic severity of typhoid fever, where the bacteria survive intracellularly within macrophages to spread throughout the body. Other critical pathogens addressed include Shigella, which causes bacillary dysentery through low-dose fecal-oral transmission, and Vibrio cholerae, the agent of epidemic cholera known for inducing massive, life-threatening fluid loss via a specialized enterotoxin. The chapter also highlights the unique adaptations of Campylobacter and Helicobacter pylori; the former is a leading cause of foodborne illness from poultry, while the latter utilizes urease production to survive the harsh acidity of the stomach, leading to chronic ulcers and increased gastric cancer risks. Additionally, the text covers Yersinia species, which can mimic appendicitis, and opportunistic organisms like Klebsiella, Proteus, and Serratia that frequently cause nosocomial infections such as pneumonia and urinary tract complications. Diagnosis often relies on selective media like MacConkey agar to differentiate species based on lactose fermentation, while treatment focuses on fluid replacement for intestinal distress and targeted antibiotic therapy for systemic or extraintestinal infections, guided by susceptibility testing due to rising drug resistance.